Tower Research Capital LLC (Trc) Gh Research PLC Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.88 - $12.74 $31,630 - $51,138	-4,014 Reduced 98.5%	61 $0
Q1 2023 May 09, 2023	BUY	$6.02 - $10.92 $17,445 - $31,646	2,898 Added 246.22%	4,075 $33,000
Q4 2022 Feb 10, 2023	SELL	$9.2 - $13.5 $20,295 - $29,781	-2,206 Reduced 65.21%	1,177 $11,000
Q3 2022 Nov 10, 2022	BUY	$10.15 - $16.15 $25,232 - $40,148	2,486 Added 277.15%	3,383 $39,000
Q2 2022 Aug 15, 2022	BUY	$8.99 - $19.87 $8,064 - $17,823	897 New	897 $8,000
Q3 2021 Nov 15, 2021	SELL	$16.51 - $23.68 $13,818 - $19,820	-837 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.25 - $21.73 $16,112 - $18,188	837 New	837 $18,000

27.8M

2.8K

3.8K

Ticker GHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,020,800
Market Cap $380M
Description
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.